Helen Rogers, MD
Obstetrics & Gynecology · Mobile, ALNPI 1609972611
Payments from drug & device makers
Across 79 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$324
- Pfizer$259
- Bayer$113
- Astellas Pharma US Inc$102
- Mylan Pharmaceuticals Inc.$68
- Baxter Healthcare$61
- plus $344 from 19 others
What the payments were for
- Food & beverage$1,25899%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $324 |
| Pfizer | 17 | $259 |
| Bayer | 6 | $113 |
| Astellas Pharma US Inc | 6 | $102 |
| Mylan Pharmaceuticals Inc. | 5 | $68 |
| Baxter Healthcare | 3 | $61 |
| Therapeuticsmd, Inc. | 3 | $35 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Hologic Sales And Service, LLC | 2 | $26 |
| Duchesnay USA Incorporated | 1 | $24 |
| Sage Therapeutics, LLC | 1 | $22 |
| Bausch Health US, LLC | 1 | $21 |
| Radius Health, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Teleflex LLC | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Exeltis, USA Inc. | 1 | $14 |
| Organon | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Lupin Inc. | 1 | $12 |
| Agile Therapeutics, Inc. | 1 | $12 |
How this compares
$1,272 in reported general payments places this provider in the 40th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 120 | $3,254 |
| Risedronate Sodium | 15 | $2,783 |
| ProgesteroneProgesterone, Micronized | 31 | $1,947 |
| Estradiol (Twice Weekly)Estradiol | 12 | $1,345 |
| Fluconazole | 84 | $572 |
| Medroxyprogesterone Acetate | 23 | $484 |
| Duloxetine Hcl | 12 | $318 |
| Terconazole | 13 | $307 |
| Zolpidem Tartrate | 35 | $245 |
| Metronidazole | 15 | $218 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $216 |
| Trazodone Hcl | 16 | $115 |
| Ciprofloxacin Hcl | 11 | $68 |
| Alprazolam | 20 | $27 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Mobile
- Charles RogersMobile$1.8M
- Amy McCoyMobile$1.2M
- Theodore CatranisMobile$994K
- Phillip MadoniaMobile$574K
- Tracy RothMobile$289K
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Judith WilliamsMobile$97K
- Melinda FrameMobile$16K
- Quin BixlerMobile$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.